Hong Kong stocks surged: Jinshi Biotechnology (01548.HK) rose more than 13% in the afternoon, with CARVYKTI sales reaching US$657 million in the second quarter, a nearly 50% year-on-year increase.

According to the Wisdom Financial News APP, Kingsway Biotech (01548.HK) rose more than 13% in the afternoon session, with a increase of 11.66% to HK$16.37 as of the time of publication, with a turnover of HK$754 million.